Skip to main content

Saturn Medic

Question Bank

Targeted & Biologic Cancer Therapy — Chemotherapy, Immunopharmacology & Toxicology

Pharmacology Question Bank

Free preview — 5 of 30 Targeted & Biologic Cancer Therapy questions. Create a free student account to unlock all 30 questions in this topic.
Create free account
Pharmacology Question Bank
Targeted & Biologic Cancer Therapy
Chemotherapy, Immunopharmacology & Toxicology · Targeted & Biologic Cancer Therapy · medium
Question 1 of 5
20% complete
0 s
Q1
Accuracy
No answers yet
Quick Tip
Question Navigator
Current
Correct
Incorrect
Unanswered

Targeted & Biologic Cancer Therapy MCQs: practice questions

Sample Targeted & Biologic Cancer Therapy multiple-choice questions from Chemotherapy, Immunopharmacology & Toxicology.

  1. Which targeted agent is an oral small-molecule inhibitor rather than a monoclonal antibody?

    • A. Trastuzumab
    • B. Imatinib
    • C. Rituximab
    • D. Cetuximab
    • E. Bevacizumab
  2. Which agent is most directly associated with B-cell lysis through antibody-dependent cytotoxicity or complement cytotoxicity?

    • A. Bevacizumab
    • B. Gefitinib
    • C. Imatinib
    • D. Rituximab
    • E. Erlotinib
  3. Which tyrosine kinase inhibitor specifically targets the Bcr-Abl oncoprotein?

    • A. Bevacizumab
    • B. Trastuzumab
    • C. Cetuximab
    • D. Imatinib
    • E. Rituximab
  4. Which monoclonal antibody binds CD20 on B lymphocytes?

    • A. Rituximab
    • B. Trastuzumab
    • C. Cetuximab
    • D. Panitumumab
    • E. Bevacizumab
  5. Which biologic agent is a recombinant interleukin-2 used for metastatic kidney cancer and melanoma?

    • A. Aldesleukin
    • B. Thalidomide
    • C. Imatinib
    • D. Interferon alfa-2b
    • E. Bortezomib
  6. Which monoclonal antibody targets HER2/neu?

  7. Which drug inhibits VEGF signaling rather than a tyrosine kinase?

  8. Which adverse-effect combination is characteristic of erlotinib?

  9. Which adverse effect is characteristic of gefitinib?

  10. Cetuximab is used for which malignancy according to the discussion?

  11. Which adverse effect is most characteristic of cetuximab?

  12. Which additional tumor expresses c-kit and can respond to imatinib?

  13. Rituximab is particularly used in the treatment of which malignancy?

  14. Which targeted agent is associated with edema, nausea, and vomiting as major toxicities?

  15. Which monoclonal antibody blocks the epidermal growth factor receptor (EGFR)?

  16. Which drug is an analog of thalidomide with increased potency and apparently decreased toxicity?

  17. Which agent is a humanized IgG antibody against HER2/neu?

  18. Which biologic agent is approved for hairy-cell leukemia and Kaposi sarcoma?

  19. Which agent is a chimeric human-mouse IgG antibody against EGFR?

  20. Which agent targets HER2/neu rather than EGFR?

  21. Gefitinib is used in the treatment of which cancer?

  22. Which EGFR tyrosine kinase inhibitor is also used in advanced pancreatic cancer?

  23. Trastuzumab is most directly associated with treatment of which tumor?

  24. Which targeted drug inhibits epidermal growth factor receptor tyrosine kinase?

  25. Which monoclonal antibody targets vascular endothelial growth factor (VEGF)?

  26. Which drug inhibits several kinases but is specifically used against Bcr-Abl and also has activity in ALL?

  27. Which drug is most directly associated with a severe rash due to EGFR blockade?

  28. Which immunomodulatory drug is highly teratogenic and used in multiple myeloma?

  29. Which biologic agent binds CD20 rather than a growth-factor receptor?

  30. Which cancer is classically associated with the Bcr-Abl translocation targeted by imatinib?

SaturnMedic